about
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trialOncogenic potential of mouse translation elongation factor-1 delta, a novel cadmium-responsive proto-oncogeneAntisense inhibition of translation initiation factor 3 reverses its oncogenic potentialThe tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phaseWidely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis(C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancerPituitary pathology in Carney complex patientsTranscriptional profiling of Krüppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiationBinding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor proteinp38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanismsEvolution of cooperation among tumor cellsIncreased expression of a Myc target gene Mina53 in human colon cancerEnhanced cell survival of gastric cancer cells by a novel gene URG4A novel form of the plasminogen activator inhibitor created by cysteine mutations extends its half-life: relevance to cancer and angiogenesis.Cancer: looking for simplicity and finding complexity.Myosins as fundamental components during tumorigenesis: diverse and indispensableCRISPR/Cas9 and cancer targets: future possibilities and present challengesMass Spectrometry-Based N-Glycomics of Colorectal CancerMolecular concept in human oral cancerReprogramming of gastrointestinal cancer cellsTranscriptome and proteome research in veterinary science: what is possible and what questions can be asked?Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinomaNanotechnology-based drug delivery systems for treatment of oral cancer: a reviewThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateEmerging patterns of somatic mutations in cancerEvolution of the cancer genomeAcquisition order of Ras and p53 gene alterations defines distinct adrenocortical tumor phenotypesHepatitis C Virus Causes Uncoupling of Mitotic Checkpoint and Chromosomal Polyploidy through the Rb PathwayRewriting the epigenetic code for tumor resensitization: a review.Colorectal Cancer Screening: Stool DNA and Other Noninvasive ModalitiesTargeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and TreatmentInnovative cancer drug targets: genomics, transcriptomics and clinomicsIdentification of cancer genes by mutational profiling of tumor genomesChemogenomics: an emerging strategy for rapid target and drug discoveryFunctionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancerSystematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancerExtra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastasesCaveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor geneBreast cancer risk and environmental exposuresRole of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases
P2860
Q21261279-503BEE00-F061-4988-A0DD-6E39995A37BFQ23919609-533A59B2-D603-428E-BAE2-37D79E075BA7Q23924038-ADEE82F9-6BE9-44D2-8DC4-B82CC1F6C867Q24310213-E89EE59B-44B5-4F13-97A0-51C5ACE3E93EQ24561466-60D562DD-DCA9-4D20-8404-ED6EEDC37257Q24564525-448331C1-4773-4DD6-BE16-62C900365955Q24647038-CAC0777B-F8E8-4FA7-84BD-6C31B240BA8BQ24648756-5B631E81-3972-4DF7-AA17-A8B73F2C0008Q24654803-A5349CE3-A70F-4B17-891A-62D8A0B42480Q24657888-99A51575-9D84-4A0F-B0F4-12B51C48ECEDQ24671009-E7329F9B-950F-47A3-96A4-E044910A7ECDQ24675943-B2C48DA6-E735-48ED-80CD-AA2760A7AE4AQ24681927-89A82B7F-5BC4-457C-952E-542C57DB8290Q24791775-13B498F6-3654-4A40-BBFF-798A4CD7AA53Q25257555-3B0D9B92-384B-41DD-A3FB-7DBAF7F4AB1AQ26749344-E2CDEB5F-6EE9-4333-AABE-EAF1965BC321Q26769907-12FAF480-0E50-4FCB-B0D2-9A798F77F683Q26774414-41937F8C-1460-4191-95C5-DCB2A7CCE60BQ26775850-36302431-C501-4794-AB89-9FD64DC36285Q26824284-E6EC7783-A596-488B-A2D9-2C761B617D2FQ26824312-75908D56-985E-4C8A-95F8-711582476768Q26849546-97FDBC4B-98F9-4E14-943E-921FC9A19B4BQ26995835-3AE99EAC-F42F-4C1C-80F2-9113095A0FB9Q27003050-F0A50300-3128-4967-8C07-242D68083178Q27014126-D1F2F118-9EC2-4938-A4DF-DBA2AE59E578Q27020991-1FB20605-610C-4C94-96D5-632D12C95E17Q27333989-6F1DDA80-609F-48BE-896A-F02EA05F55D7Q27490465-85DD29D7-575C-4BD3-BEA6-87FCFF3C4F06Q27687583-93C6FC38-CBB7-42B5-86B9-C820B53D1658Q28070230-74EDC2E1-7C3B-4CC7-B2FA-134E8E3A3AFDQ28076462-F0C74D86-8B7E-4ABC-88D6-A820C54380E7Q28190114-BE35C046-8D93-4A8D-92B5-C34003EC083AQ28239452-DE066ADE-6242-4A39-9CE4-0B3AF38EC325Q28260664-AD1250C4-7CA7-4ABF-B696-A148658FFD55Q28277653-E1D51E77-A172-4605-A4BE-E2B43543ED86Q28297342-49C526CC-EC87-48BF-8C06-D1E0ED35F95BQ28345479-03B5D2C8-5810-4D75-8791-75DC5A156A65Q28363368-8EA0FFA4-10B4-4755-955D-97F57E2B5305Q28388844-64A53164-9B47-483B-A1BA-F7E66EE14FBFQ28389566-468A0E33-B947-4F11-ADC6-974AB80FF66F
P2860
description
1993 nî lūn-bûn
@nan
1993 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
The multistep nature of cancer.
@ast
The multistep nature of cancer.
@en
The multistep nature of cancer.
@nl
type
label
The multistep nature of cancer.
@ast
The multistep nature of cancer.
@en
The multistep nature of cancer.
@nl
prefLabel
The multistep nature of cancer.
@ast
The multistep nature of cancer.
@en
The multistep nature of cancer.
@nl
P1433
P1476
The multistep nature of cancer.
@en
P304
P356
10.1016/0168-9525(93)90209-Z
P577
1993-04-01T00:00:00Z